Literature DB >> 3342506

What is the cause of benign transient hyperphosphatasemia? A study of 35 cases.

P M Crofton1.   

Abstract

In a study of 35 children with benign transient hyperphosphatasemia, I found a marked seasonal clustering of cases after the summer months. Furthermore, plasma 25-hydroxyvitamin D concentrations were almost twice those of controls matched for age and time of year. Many children had evidence of weight loss and one had idiopathic hypercalcemia of infancy. Activities both of liver and bone isoenzymes of alkaline phosphatase (EC 3.1.3.1) in plasma were increased. The liver and (to a lesser extent) bone isoenzymes had enhanced electrophoretic mobility, and both showed increased binding to wheat-germ lectin by affinity electrophoresis. For the liver (and probably also the bone) isoenzyme, these changes were due to an increased content of sialic acid. A possible etiology for the condition is proposed involving (a) increased synthesis of alkaline phosphatase, mediated by vitamin D metabolites, and (b) decreased hepatic clearance caused by the high sialic acid content and exacerbated in some cases by the effects of some drugs on the liver.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342506

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Transient rise in alkaline phosphatase activity in adults.

Authors:  Nuthar Jassam Jassam; Janet Horner; Helena Marzo-Ortega; Margaret Sinclair; Julian H Barth
Journal:  BMJ Case Rep       Date:  2009-12-03

2.  Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report.

Authors:  T Hranjec; H Bonatti; A L Roman; C Sifri; S M Borowitz; B H Barnes; T R Flohr; T L Pruett; R G Sawyer; T M Schmitt
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

3.  Differential diagnosis and work-up of elevations of alkaline phosphatase following therapy for pediatric cancer.

Authors:  Jessica R Roberson; Sue C Kaste; Victor M Santana; Wayne L Furman
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

4.  Transient hyperphosphatasaemia of infancy and failure to thrive.

Authors:  E M Baildam; M Z Mughal; M Dalton; M A Lewis
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

5.  Benign transient hyperphosphatasemia in an infant during zinc supplementation.

Authors:  Ayça Bilge Sönmez; İlter Arifoğlu; Ahmet Yıldırım; Filiz Tütüncüler
Journal:  Turk Pediatri Ars       Date:  2018-06-01

6.  Prevalence of transient hyperphosphatasemia among healthy infants and toddlers.

Authors:  Susanna Y Huh; Henry A Feldman; Joanne E Cox; Catherine M Gordon
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

7.  Normal bone turnover in transient hyperphosphatasemia.

Authors:  Stepan Kutilek; Barbora Cervickova; Pavla Bebova; Marie Kmonickova; Vladimir Nemec
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.